Robert J. Gould, Director: Fulcrum Therapeutics FULC Sell · Filed 25/11/21

Trade details

Type: Insider sale
Amount: $165,450
Shares · price: 15,000 sh · $11.03 a share
Held after: 484,864 sh
Stock: Fulcrum Therapeutics FULC
Person: Robert J. GouldDirector
Trade date: 25/11/19
Filed: 25/11/21
Days to filing: 2 days

Sold 3.0% of holdings

Share of holding sold: 3.0%

Fulcrum Therapeutics trades, last 26 weeks

What else happened in Fulcrum Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/20~25/12/19

Robert J. Gould's recent trades

Robert J. GouldDirector
SellFulcrum Therapeutics
Sell
Fulcrum Therapeutics
FULC
$163.1K
15,000 sh
$163.1K
Filed 02/04
Traded 01/02
Robert J. GouldDirector
SellFulcrum Therapeutics
Sell
Fulcrum Therapeutics
FULC
$160.8K
15,000 sh
$160.8K
Filed 02/04
Traded 02/02
Robert J. GouldDirector
SellFulcrum Therapeutics
Sell
Fulcrum Therapeutics
FULC
$178.1K
15,000 sh
$178.1K
Filed 01/06
Traded 01/02
Robert J. GouldDirector
Planned sale10b5-1 planFulcrum Therapeutics
Planned sale10b5-1 plan
Fulcrum Therapeutics
FULC
$437.9K
45,000 sh
$437.9K
Filed 25/11/19
Traded 25/11/19
Robert J. GouldInterim President & CEO
SellFulcrum Therapeutics
Sell
Fulcrum Therapeutics
FULC
$101.5K
6,766 sh
$101.5K
Filed 23/01/13
Traded 23/01/13